Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme

Technology in Cancer Research and Treatment

Volumn 7, Issue 3, 2008, Pages 249-255

  Lipani, John D ^a,c   Jackson, Paul S ^a   Soltys, Scott G ^a   Sato, Kengo ^b   Adler, John R ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b Yokohama CyberKnife Center   (Japan)

^c Capital Health System   (United States)

Author keywords

CyberKnife; GBM; Hypofractionated radiotherapy; Stereotactic radiosurgery

Indexed keywords

NIMUSTINE; VINCRISTINE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; MALE; RADIATION DOSE; RADIOSURGERY; RETROSPECTIVE STUDY; TUMOR BIOPSY; TUMOR VOLUME;

EID: 45349107465     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460800700311     Document Type: Article

References (43)

1. Bruner, J. M. Neuropathology of malignant gliomas. Semin Oncol 21, 126-138 (1994).
2. Deorah, S., Lynch, C. F., Sibenaller, Z. A., Ryken, T. C. Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. Neurosurg Focus 20, E1 (2006).
3. Burger, P. C., Vogel, F. S., Green, S. B. Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 56, 1106-1111 (1985).
4. Coffey, R. J., Lunsford, L. D., Taylor, F. H. Survival after stereotactic biopsy of malignant gliomas. Neurosurgery 22, 465-473 (1988).
5. Nelson, D. F., Nelson, J. S., Davis, D. R., et al. Survival and prognosis of patients with astrocytomas with atypical or anaplastic features. J Neuro-Oncol 3, 99-108 (1985).
6. Stupp, R., Mason, W. P., van den Bent, M. J., et al. Radiotherapy plus Concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352, 10 (2005).
7. Mirimanoff, R., Mason, W. P., van den Bent, M. J., Kortmann, R., et al. Is Long-Term Survival in Glioblastoma Possible? Updated Results of the EORTC/NCIC Phase III Randomized Trial on Radiotherapy (RT) and Concomitant and Adjuvant Temozolomide (TMZ) versus RT Alone, Int J Radiat Oncol Biol Phys 69, Issue 3, Supplement 1, Proceedings of the American Society for Therapeutic Radiology and Oncology 49th Annual Meeting, 49th Annual Meeting of the American Society for Therapeutic Radiology and Oncology 1, Page S2. November (2007).
8. Keles, G. E., Anderson, B., Berger, M. S. The Effect of Extent of Resection on Time to Tumor Progression and Survival in Patients Glioblastoma Multiforme of the Cerebral Hemisphere. Surg Neurol 52, 371-379 (1999).
9. Wood, J. R., Green, S. B., Shapiro, W. R. The prognostic importance of tumor size in malignant gliomas: A computed tomographic scan study by the brain tumor cooperative group. J Clin Oncology 6, 338-343 (1988).
10. Byar, D. P., Green, S. B., Strike, T. A. Prognostic Factors for malignant glioma, In Oncology of the nervous system, pp. 379-395. Ed., Walk, M. D. Boston, MA, Marinus Nijhoff (1983).
11. Silbergeld, D. L., Rostomily, R. C., Alvord, E. C., Jr. The cause of death in patients with glioblastoma is multifactorial: clinical factors and autopsy findings in 117 cases of supratentorial glioblastoma in adults. J Neurooncol 10, 179-185 (1991).
12. Gilbert, M. R., Loghin, M. The Treatment of Malignant Gliomas. Curr Treat Options Neurol 7, 293-303 (2005).
13. Walker, M. D., Alexander, E., Hunt W. E., et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 49, 333-343 (1978).
14. Walker, M. D., Strike, T. A., Shelino, G. E. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5, 1725-1731 (1979).
15. Kristiansen, K., Hagen, S., Kollevoid, T., et al. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time. A prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 47, 649-652 (1981).
16. Ammirati, M., Galicich, J. H., Arbit, E., Liao, Y. Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery 21, 607-614 (1987).
17. Hochberg, F. H., Pruitt, A. Assumptions in the radiotherapy of glioblastoma. Neurology 30, 907-911 (1980).
18. Masciopinto, J. E., Levin, A. B., Mehta, M. P., Rhode, B. S. Stereotactic radiosurgery for glioblastoma: a final report of 31 patients. J Neurosurg 82, 530-535 (1995).
19. Wallner, K. E., Galicich, J. H., Krol, G., Arbit, E., Malkin, M. G. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 16, 1405-1409 (1989).
20. Shapiro, W. R., Green, S. B., Burger, P. C., et al. Randomized trial of three chemotherapy regimens and two radiotherapy regimens in post-operative treatment of malignant glioma: Brain Tumor Cooperative Group Trial 8001. J Neurosurg 71, 1-9 (1989).
21. Souhami, L., Seiferheld, W., Brachman, D., Podgorsak, E. B., et al. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys 60, 853-860 (2004).
22. Laperriere, N. J., Leung, P. M., McKenzie, S., Milosevic, M., et al. Randomized study of brachy therapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys 41, 1005-1011 (1998).
23. Selker, R. G., Shapiro, W. R., Burger, P., Blackwood, M. S., Arena, V. C., et al. Brain Tumor Cooperative Group.The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine. Neurosurgery 51, 343-355; discussion 355-357 (2002).
24. Fiveash, J. B., Spencer, S.A. Role of radiation therapy and radiosurgery in glioblastoma multiforme. Cancer J 9, 222-229 (2003).
25. Roberge, D., Souhami, L. Stereotactic radiosurgery in the management of intracranial gliomas. Technol Cancer Res Treat 2, 117-125 (2003).
26. Curran, W. J., Jr., Scott, C. B., Horton, J., Nelson, J. S., Weinstein, A. S., Fischbach, A. J., et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85, 704-710 (1993).
27. Collins, S. P., Coppa, N. D., Zhang, Y., Collins, B. T., McRae, D. A., Jean, W. C. CyberKnife(R) radiosurgery in the treatment of complex skull base tumors: analysis of treatment planning parameters. Radiat Oncol 1, 46 (2006).
28. Adler, J. R., Jr., Murphy, M. J., Chang, S. D. et al. Image-guided robotic radiosurgery. Neurosurgery 44, 1299-1306; discussion 1306-1297 (1999).
29. Yu, C., Jozsef, G., Apuzzo, M. L., Petrovich, Z. Dosimetric comparison of CyberKnife with other radiosurgical modalities for an ellipsoidal target. Neurosurgery 53, 1155-1162; discussion 1162-1153 (2003).
30. Burger, P. C., Dubois, P. J., Schold, S. C., Smith, K. R., Odom, G. L., Crafts, D. C., et al. Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg 58, 159-169 (1983).
31. Burger, P. C., Heinz, E. R., Shibata, T., Kleihues, P. Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 68, 698-704 (1988).
32. Halperin, E. C., Bentel, G., Heinz, E. R., Burger, P. C. Radiation therapy treatment planning in supratentorial glioblastoma multiforme: an analysis based on post mortem topographic anatomy with CT correlations. Int J Radiat Oncol Biol Phys 17, 1347-1350 (1989).
33. Kelly, P. J., Daumas-Duport, C., Scheithauer, B. W., Kall, B. A., Kispert, D. B. Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 62, 450-459 (1987).
34. Lunsford, L. D., Martinez, A. J., Latchaw, R. E. Magnetic resonance imaging does not define tumor boundaries. Acta Radiol Suppl 369, 154-156 (1986).
35. Miwa, K., Shinoda, J., Yano, H., Okumura, A., Iwama, T., Nakashima, T., et al. Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: insight from a PET and MR fusion image study. J Neurol Neurosurg Psychiatry 75, 1457-1462 (2004)
36. Chan, A. A., Lau, A., Pirzkall, A., Chang, S. M., Verhey, L. J., Larson, D., et al. Proton magnetic resonance spectroscopy imaging in the evaluation of patients undergoing gamma knife surgery for Grade IV glioma. J Neurosurg 101, 467-475 (2004)
37. Hsieh, P. C., Chandler, J. P., Bhangoo, S., Panagiotopoulos, K., Kalapurakal, J. A., Marymont, M. H., et al. Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme. Neurosurgery 57, 684-692; discussion 684-692 (2005).
38. Kondziolka, D., Flickinger, J. C., Bissonette, D. J., Bozik, M., Lunsford, L. D. Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms. Neurosurgery 41, 776-783; discussion 783-775 (1997)
39. Mahajan, A., McCutcheon, I. E., Suki, D., Chang, E. L., Hassenbusch, S. J., Weinberg, J. S., et al. Case-control study of stereotactic radiosurgery for recurrent glioblastoma multiforme. J Neurosurg 103, 210-217 (2005)
40. Sarkaria, J. N., Mehta, M. P., Loeffler, J. S., Buatti, J. M., Chappell, R. J., Levin, A. B., et al. Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 32, 931-941 (1995)
41. Mirimanoff, R. O., Gorlia, T., Martin, W., Van den Bent. M. J., et al. Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Recursive Partitioning Analysis of the EORTC 26981/22981 - NCIC CE3 Phase III Randomized Trial. J Clin One 24, 2563-2569 (2006).
42. Ciric, I., Vick, N. A., Mikhael, M. A., Cozzens, J., Eller, T., Walsh, A. Aggressive surgery for malignant supratentorial gliomas. Clin Neurosurg 36, 375-383 (1990)
43. Hentschel, S. J., Sawaya, R. Optimizing outcomes with maximal surgical resection of malignant gliomas. Cancer Control 10, 109-114 (2003).